FORUM SESSIONS

FORUM SESSIONS

​2019 FORUM DISCUSSIONS

These novel Fora, in WEF-style format, will bring together corporate participants, neuroscientists and clinicians with outstanding experience in "hottest" research topics in the field of neurodegeneration to discuss the impact of newest preclinical results and cutting edge clinical findings on understanding and treatment development of neurodegenerative disorders. The objective is to exchange novel insights, challenges and solutions on the joint path forward to defining the future of AD and PD therapeutics.

Each forum will be 60 minutes moderated discussion with maximum 3 minutes introduction statement from each participant followed by questions from the audience submitted via Ask the Speaker function in the mobile APP and introduced to the discussion by the moderator. The forum is also open for journalists from different media, including lay press in and may report on progress made by the leaders in this field.

 

Wednesday,  March 27. 2019  - Forum on Biomarkers and Imaging in AD and PD 
Moderators: 
Henrik Zetterberg
UNIVERSITY OF GOTHENBURG, SWEDEN
Angela Genge MCGILL UNIVERSITY, CANADA
Discussants: 
John Beaver
BIOGEN, USA
Gregory Klein ROCHE, SWITZERLAND
​Bjorn Sperling
​LUNDBECK
​Andrew Stephens

​LIFE MOLECULAR IMAGING GmbH, GERMANY

 
 
Thursday, March 28, 2019 - Forum on Translational R&D in AD  
Moderators: 
Manfred WindischNEUROSCIOS, AUSTRIA 
Todd GoldeEVELYN F. AND WILLIAM L. MCKNIGHT BRAIN INSTITUTE; FLORIDA ALZHEIMER'S DISEASE RESEARCH CENTER  AND UNIVERSITY OF FLORIDA, USA
Discussants: 
Anirvan Ghosh  BIOGEN, USA
Kelly BalesROCHE, USA

Akihiko Koyama 

EISAI, USA
John Morris
WASHINGTON UNIVERSITY, USA

 
Friday, March 29, 2019 - Forum on Novel Therapeutic Strategies of PD & LBD
Moderators: 
Walter KoroshetzNINDS, USA
Jaime EberlingMICHAEL J FOX FOUNDATION, USA
Discussants: 
Pierandrea Muglia UNION CHIMIQUE BELGE , BELGIUM
Jesse Cedarbaum BIOGEN, USA
Nadeem Sarwar
EISAI, USA

​Andrew Satlin 

​INTRACELLULAR THERAPIES, USA
 
 
Saturday,  March 30, 2019 - Alzheimer Clinical Phase 3 Forum 
Moderators: 
John Growdon
HARVARD UNIVERSITY,USA
Randall Bateman
WASHINGTON UNIVERSITY, USA
Discussants: 
Geoff Kerchner
ROCHE, SWITZERLAND
John Sims
ELI LILLY, USA
Philipp von Rosenstiel BIOGEN, USA
Chad Swanson
EISAI, USA


Watch the full AD/PDTM 2017 Forum Discussion Sessions